Eversept Partners LP Decreases Position in HCA Healthcare, Inc. $HCA

Eversept Partners LP lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 14.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 95,874 shares of the company’s stock after selling 15,826 shares during the quarter. HCA Healthcare comprises about 2.3% of Eversept Partners LP’s holdings, making the stock its 10th biggest position. Eversept Partners LP’s holdings in HCA Healthcare were worth $44,760,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Nordea Investment Management AB raised its stake in shares of HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after buying an additional 108,849 shares during the period. Nomura Asset Management Co. Ltd. grew its position in shares of HCA Healthcare by 6.2% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after purchasing an additional 3,724 shares in the last quarter. Hudson Bay Capital Management LP grew its position in shares of HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after purchasing an additional 2,849 shares in the last quarter. Advisors Capital Management LLC grew its position in shares of HCA Healthcare by 61.5% during the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC grew its position in shares of HCA Healthcare by 1,062.4% during the fourth quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after purchasing an additional 8,733 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $387.87 on Thursday. The stock has a market cap of $86.05 billion, a price-to-earnings ratio of 13.34, a price-to-earnings-growth ratio of 1.26 and a beta of 1.12. The stock has a 50 day moving average price of $424.54 and a 200-day moving average price of $470.67. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Sanford C. Bernstein cut their target price on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research report on Thursday, June 4th. Truist Financial set a $413.00 target price on HCA Healthcare in a research report on Thursday, June 4th. Stephens cut their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Royal Bank Of Canada cut their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.